Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
For this drug, the ongoing SOUL trial has shown promising preliminary results, indicating a 14% reduction in the risk of MACE (84)
It does not contain semaglutide, tirzepatide or any prescription drug
John Cawley, a professor of economics and public policy at Cornell University who has studied the economic impacts of obesity, has found that obesity essentially doubles a persons annual health care costs due to comorbidities such as heart disease, fatty liver disease and kidney disease
Healthier, balanced diets may enhance the medications effectiveness
But, it will be hard for smaller PBMs to compete with them on trend
US$ 26.61
US$ 29.85
US$ 28.80
US$ 21.50
US$ 29.70
US$ 24.14
US$ 27.03
US$ 27.56
US$ 21.85
US$ 20.92
